Evidence map›Paper›PMID 39753670›Full record

ArticleNature microbiology2025

Phenotypic evolution of SARS-CoV-2 spike during the COVID-19 pandemic.

Wilhelm Furnon, Vanessa M Cowton, Giuditta De Lorenzo, Richard Orton, Vanessa Herder, Diego Cantoni, Georgios Ilia, Diogo Correa Mendonca, Karen Kerr, Jay Allan and 16 more

Abstract read
In one paragraph

Article in Nature microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Switching Spike Plasticity Shapes ACE2 Engagement Across SARS-CoV-2 Variants.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  2. Viral syncytia evolve to resist interferon.Nature communications · 2026
    Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors.

Wilhelm Furnon *MRC-University of Glasgow Centre for Virus Research, Glasgow, UK.ORCID http://orcid.org/0000-0002-5588-4232
Vanessa M Cowton *MRC-University of Glasgow Centre for Virus Research, Glasgow, UK.ORCID http://orcid.org/0000-0003-1813-7825
Giuditta De Lorenzo *MRC-University of Glasgow Centre for Virus Research, Glasgow, UK.ORCID http://orcid.org/0000-0002-2736-8740
Richard OrtonMRC-University of Glasgow Centre for Virus Research, Glasgow, UK.
Vanessa HerderMRC-University of Glasgow Centre for Virus Research, Glasgow, UK.ORCID http://orcid.org/0000-0003-4814-1382
Diego CantoniMRC-University of Glasgow Centre for Virus Research, Glasgow, UK.
Georgios IliaMRC-University of Glasgow Centre for Virus Research, Glasgow, UK.ORCID http://orcid.org/0009-0003-4109-5966
Diogo Correa MendoncaMRC-University of Glasgow Centre for Virus Research, Glasgow, UK.
Karen KerrMRC-University of Glasgow Centre for Virus Research, Glasgow, UK.
Jay AllanMRC-University of Glasgow Centre for Virus Research, Glasgow, UK.
Nicole UpfoldMRC-University of Glasgow Centre for Virus Research, Glasgow, UK.
Gavin R MeehanMRC-University of Glasgow Centre for Virus Research, Glasgow, UK.
Siddharth BakshiMRC-University of Glasgow Centre for Virus Research, Glasgow, UK.
Udeet Ranjan DasMRC-University of Glasgow Centre for Virus Research, Glasgow, UK.
Sergi Molina AriasMRC-University of Glasgow Centre for Virus Research, Glasgow, UK.ORCID http://orcid.org/0009-0004-5109-9095
Marion McElweeMRC-University of Glasgow Centre for Virus Research, Glasgow, UK.
Sarah LittleMRC-University of Glasgow Centre for Virus Research, Glasgow, UK.
Nicola LoganMRC-University of Glasgow Centre for Virus Research, Glasgow, UK.
Kirsty KwokMRC-University of Glasgow Centre for Virus Research, Glasgow, UK.
Katherine SmollettMRC-University of Glasgow Centre for Virus Research, Glasgow, UK.
Brian J WillettMRC-University of Glasgow Centre for Virus Research, Glasgow, UK.ORCID http://orcid.org/0000-0001-8912-3266
Ana Da Silva FilipeMRC-University of Glasgow Centre for Virus Research, Glasgow, UK.ORCID http://orcid.org/0000-0002-9442-2903
David L RobertsonMRC-University of Glasgow Centre for Virus Research, Glasgow, UK.ORCID http://orcid.org/0000-0001-6338-0221
Joe GroveMRC-University of Glasgow Centre for Virus Research, Glasgow, UK.ORCID http://orcid.org/0000-0001-5390-7579
Arvind H PatelMRC-University of Glasgow Centre for Virus Research, Glasgow, UK. arvind.patel@glasgow.ac.uk.ORCID http://orcid.org/0000-0003-4600-2047
Massimo PalmariniMRC-University of Glasgow Centre for Virus Research, Glasgow, UK. massimo.palmarini@glasgow.ac.uk.ORCID http://orcid.org/0000-0001-7007-4070

Funding

Medical Research Council MR/W005611/1Medical Research Council MR/Y004205/1RCUK | Medical Research Council (MRC) MC_UU_00034/5RCUK | Medical Research Council (MRC) MC_UU_00034/9RCUK | Medical Research Council (MRC) MC_UU_0034/6RCUK | Medical Research Council (MRC) MC_UU_0034/7RCUK | Medical Research Council (MRC) MC_UU_0034/8RCUK | Medical Research Council (MRC) MR/Y004205Wellcome TrustWellcome Trust (Wellcome) 226141/Z/22/Z
6 · The paper itself

Abstract

SARS-CoV-2 variants are mainly defined by mutations in their spike. It is therefore critical to understand how the evolutionary trajectories of spike affect virus phenotypes. So far, it has been challenging to comprehensively compare the many spikes that emerged during the pandemic in a single experimental platform. Here we generated a panel of recombinant viruses carrying different spike proteins from 27 variants circulating between 2020 and 2024 in the same genomic background. We then assessed several of their phenotypic traits both in vitro and in vivo. We found distinct phenotypic trajectories of spike among and between variants circulating before and after the emergence of Omicron variants. Spike of post-Omicron variants maintained enhanced tropism for the nasal epithelium and large airways but displayed, over time, several phenotypic traits typical of the pre-Omicron variants. Hence, spike with phenotypic features of both pre- and post-Omicron variants may continue to emerge in the future.

Indexed as

COVID-19SARS-CoV-2Spike Glycoprotein, CoronavirusAnimalsEvolution, MolecularHumansMutationPandemicsPhenotypeViral TropismSpike Glycoprotein, Coronavirusspike protein, SARS-CoV-2

Identifiers

PMID39753670
PMCPMC11726466

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.